Real-World Bruton Tyrosine Kinase Inhibitor (BTKi) Treatment Patterns Among Patients with Chronic or Small Lymphocytic Leukemia (CLL/SLL) in US Community Oncology Practices

被引：0

作者：

Hou, Jing-Zhou ^{[1
,2
]}

Blanc, Simon ^{[3
]}

Maglinte, Gregory A. ^{[4
]}

Vasudevan, Anupama ^{[3
]}

Rui, Anna ^{[3
]}

Gart, Michael ^{[5
]}

Hoa Pham ^{[4
]}

Aton, Lindsay ^{[3
]}

Wang, Brandon ^{[3
]}

Choksi, Rushir ^{[6
]}

机构：

[1] UPMC Hillman Canc Ctr, Lemieux Ctr Blood Canc, Hematol & BMT, Pittsburgh, PA USA

[2] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA

[3] Integra Connect PrecisionQ, W Palm Beach, FL USA

[4] BeiGene USA Inc, San Mateo, CA USA

[5] Integra Connect, W Palm Beach, FL USA

[6] Univ Pittsburgh, Med Ctr, Hillman Canc Ctr, Pittsburgh, PA USA

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-174915

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[21] Prospective Patient Preference Study for Bruton Tyrosine Kinase Inhibitor (BTKi) Treatment Attributes and Factors Affecting Patient Shared Decision-Making in Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL) in the United States (USA) [J].

Ailawadhi, Sikander ;

Challagulla, Swetha ;

Pilon, Dominic ;

Meng, Yan ;

Xue, Mei ;

Wang, Yuxi ;

Yang, Keri .

BLOOD, 2024, 144 :2265-2266

[22] BRUTON TYROSINE KINASE INHIBITOR (BTKI) MONOTHERAPY FOR THE TREATMENT OF 'HIGH-RISK' PATIENTS WITH PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): A SYSTEMATIC LITERATURE REVIEW (SLR) [J].

Mohseninejad, L. ;

Walder, L. ;

Ubi, S. ;

Malyon, A. ;

Yang, K. ;

Olie, R. .

VALUE IN HEALTH, 2023, 26 (12) :S545-S545

[23] Real-world Analysis of Tyrosine Kinase Inhibitor Treatment Patterns Among Patients With Chronic Myeloid Leukemia in the United States [J].

Henk, Henry J. ;

Woloj, Mabel ;

Shapiro, Mark ;

Whiteley, Jennifer .

CLINICAL THERAPEUTICS, 2015, 37 (01) :124-133

[24] Characteristics and Outcomes of Patients Receiving Sequential Bruton's Tyrosine Kinase Inhibitor (BTKi)/B-Cell Lymphoma 2 Inhibitor (BCL2i) for Treatment of Chronic Lymphocytic Leukemia (CLL) in the Real-World (rw) Practice Setting [J].

Davids, Matthew S. ;

Ambrose, Jacob ;

De Nigris, Enrico ;

Prescott, Jennifer ;

Leng, Siyang ;

Farooqui, Mohammed Z. H. ;

Gandra, Shravanthi R. ;

Zettler, Christina M. ;

Fernandes, Laura L. ;

Wang, Ching-Kun ;

Shadman, Mazyar .

BLOOD, 2023, 142

[25] Real-world healthcare resource utilization (HRU)/costs associated with venetoclax treatment among chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) patients. [J].

Rogers, Kerry Anne ;

Emond, Bruno ;

Manceur, Ameur M. ;

Kinkead, Frederic ;

Lafeuille, Marie-Helene ;

Lefebvre, Patrick ;

Huang, Qing .

JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)

[26] Patient Characteristics, Treatment Patterns, and Outcomes Following Covalent Btki Discontinuation in a Contemporary Cohort of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Patients [J].

Lin, Kevin H. ;

Huynh, Lynn ;

Yang, Xiaoqin ;

Lema, Neema ;

Matay, Lisa ;

Balasubramanian, Sobana ;

Liborski, Daria ;

McDonough, Mikaela M. ;

Foreman, Jillian ;

Farooqui, Mohammed Z. H. ;

De Nigris, Enrico ;

Gandra, Shravanthi R. ;

Sarpong, Eric ;

Duh, Mei Sheng ;

Brown, Jennifer R. ;

Davids, Matthew S. .

BLOOD, 2022, 140 :4150-4152

[27] Healthcare Resource Utilization and Costs in Patients with Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) Treated with Covalent Btki (cBTKi): Real-World Impact of Cardiovascular Adverse Events [J].

Obeng-Kusi, Mavis ;

De Nigris, Enrico ;

Leng, Siyang ;

Farooqui, Mohammed Z. H. ;

Yapici, Halit O. ;

Weimer, Ian ;

Jiao, Weiqi ;

Hyatt, Hayden W. ;

Zhang, Xuan ;

Lodaya, Kunal ;

Dingli, David .

BLOOD, 2024, 144 :3738-3739

[28] Systematic literature review (SLR) of treatments and outcomes in patients with relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) previously treated with Bruton tyrosine kinase inhibitors (BTKi) and venetoclax [J].

Wang, Lin ;

Hartley, Louise ;

Hawe, Emma ;

Kangappaden, Teresa ;

Laidlaw, Alyshia ;

Sharman, Jeff .

LEUKEMIA & LYMPHOMA, 2023, 64 :S54-S55

[29] Real World Comparison of Bruton Tyrosine Kinase Inhibitors and Venetoclax in Patients Diagnosed with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [J].

Roeker, Lindsey E. ;

Han, Yi ;

Ryan, Kellie J. ;

Teschemaker, Anna ;

Mato, Anthony R. .

BLOOD, 2022, 140 :7025-7027

[30] Real-World Characterization of Ibrutinib Therapy for Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL) Patients in British Columbia (BC) [J].

Khelifi, Rania S. ;

Huang, Steven J. T. ;

Savage, Kerry J. ;

Villa, Diego ;

Scott, David W. ;

Ramadan, Khaled ;

Connors, Joseph M. ;

Sehn, Laurie H. ;

Toze, Cynthia L. ;

Gerrie, Alina S. .

BLOOD, 2020, 136

← 1 2 3 4 5 →